Oral azithromycin for treatment of intractable rosacea

Jae Hong Kim, Yoon Seok Oh, Eung Ho Choi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Rosacea is a common chronic cutaneous disorder that primarily occurs on the convex surfaces of the central face and is often characterized by exacerbations and remissions. A case of a 52-yr-old woman visited our clinic in February 2008 complaining typical features of rosacea including multiple pinhead to rice-sized erythematous papules. We applied various conventional treatments including topical benzoyl peroxide and metronidazole as well as oral metronidazole, isotretinoin, and doxycycline. The lesions were not controlled but were rather aggravated by complications from these treatments. Therefore, we prescribed oral azithromycin, which has anti-inflammatory effects and reduces reactive oxygen species. Ten weeks after the administration of oral azithromycin, 500 mg per day for 2 weeks, the lesions had mostly disappeared and no specific side effects related to the azithromycin were noted. Oral azithromycin dosing 500 mg/day for 2 weeks is effective for treatment of intractable rosacea.

Original languageEnglish
Pages (from-to)694-696
Number of pages3
JournalJournal of Korean medical science
Volume26
Issue number5
DOIs
Publication statusPublished - 2011 May

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Oral azithromycin for treatment of intractable rosacea'. Together they form a unique fingerprint.

Cite this